- Sanara MedTech (NASDAQ:SMTI) expects Q4 total revenue of ~$4.8M vs. $3.4M in year ago quarter; FY20 revenue is seen rising 32%.
- Cash and equivalents estimated at ~$0.5M as of Dec. 31, 2020.
- The company entered into a loan agreement with Cadence Bank on Jan. 15, 2021, which provides for a $2.5M revolving line of credit.
Sanara MedTech provides Q4 prelims
Recommended For You
More Trending News
About SMTI Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
SMTI | - | - |
Sanara MedTech Inc. |